You are here: Knowledge Bank Press Releases

Press Releases

Press Releases is unique and effective promotional tool offered from Worldpharmatoday.com aimed at bringing our client’s business message into limelight and more importantly make it reach their target audience. This feature can be utilized to launch new product, promoting existing Pharma product, publish business agreements, annual reports, financial results, corporate performances, important announcements or any important information that has to be conveyed to the target audience.

To add free press releases please click here.

CleveXel Pharma partners with Guilin Pharmaceutical to develop two new anti-malarial products

E-mail Print PDF

CleveXel Pharma today announces that the company has entered into a new partnering agreement with Guilin Pharmaceutical, a Chinese company located in Shanghai, regarding the development of two new products.

Pharmacy Times Reveals Pharmacists' OTC Favorites

E-mail Print PDF

The 2014 OTC Guide supplement issue, website, and mobile app, touted on the TODAY show, announce the most recommended OTC products in more than 150 categories.

Astellas Details Pipeline Progress at R&D Meeting

E-mail Print PDF

Astellas today announced progress on the Company's efforts to reshape its research framework at its R&D meeting held in Tokyo on July 10. The meeting provided an opportunity for Astellas to present a comprehensive overview of its late-stage clinical programs and corporate strategy. The purpose of the meeting was to provide an update on the initiatives for Astellas innovation, drug discovery research and pipeline progress.

Strativa Pharmaceuticals Announces FDA Approval of Nascobal® (Cyanocobalamin, USP) Nasal Spray Single-Use Device

E-mail Print PDF

One Spray per Device, Without the Need for Priming, Provides Greater Ease of Use

Weight-Loss Surgery, Prescriptions More Satisfying for Obese Patients

E-mail Print PDF

Obese patients who underwent surgery or took medications to lose weight were more satisfied with their results than those who made lifestyle changes.

Japan Approves- Oral, Interferon and Ribavirin Free Hepatitis C Treatment and others

E-mail Print PDF

Offers new treatment option for genotype 1 HCV patients in Japan who are interferon-ineligible/intolerant, or did not previously respond to treatment

Japanese HCV patients in urgent need of care now have opportunity for cure, including older patients and those with compensated cirrhosis

genOway offers industry scientists immediate access to EUCOMM conditional KO mouse models

E-mail Print PDF

genOway guarantees freedom to operate (FTO) and offers important gains in conditional knockout development time for industry scientists

Par Pharmaceutical Statement on Brevital® Sodium

E-mail Print PDF

Par Pharmaceutical Companies, Inc. today issued the following statement in response to inquiries it has received regarding the potential use of Brevital® Sodium (methohexital sodium for injection, USP) by the State of Indiana Department of Correction as part of a three-drug lethal injection protocol:

Cancer research departments need to think beyond checkpoint inhibitors

E-mail Print PDF
User Rating: / 1
PoorBest 

Cancer immunotherapy research departments need to break their obsession with the latest flavour of the month - checkpoint inhibitors - and concentrate more on combining checkpoint inhibitors with APC activators, thinks Dr. Frederic Triebel, the founder of the French biotech Immutep and an expert in immuno-oncology.

Provepharm and Dr Franz Kohler Chemie partner to provide Methylthioninium chloride Proveblue solution for injection to Germany

E-mail Print PDF

Proveblue(R) is the methylthioninium chloride or Methylene Blue active substance patented by Provepharm, compliant with current European Pharmacopeia standards

Page 1 of 63

  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  6 
  •  7 
  •  8 
  •  9 
  •  10 
  •  Next 
  •  End 
  • »